| scholarly article | Q13442814 |
| P2093 | author name string | English MA | |
| Licht JD | |||
| P2860 | cites work | Induction of Rb-associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition | Q22003911 |
| Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70 | Q24308507 | ||
| Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2 | Q24309088 | ||
| Ciao 1 is a novel WD40 protein that interacts with the tumor suppressor protein WT1 | Q24309269 | ||
| High affinity binding sites for the Wilms' tumour suppressor protein WT1 | Q24314245 | ||
| Molecular cloning of the cDNA and chromosome localization of the gene for human ubiquitin-conjugating enzyme 9 | Q24322684 | ||
| A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1 | Q24324095 | ||
| WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes | Q24596062 | ||
| Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A | Q27660274 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus | Q28236741 | ||
| Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping | Q28236877 | ||
| WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts | Q28505651 | ||
| WT-1 is required for early kidney development | Q28512266 | ||
| Truncated WT1 mutants alter the subnuclear localization of the wild-type protein | Q33635997 | ||
| Antagonism of WT1 activity by protein self-association. | Q33756936 | ||
| G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes | Q34341142 | ||
| Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1. | Q34592669 | ||
| A clinical overview of WT1 gene mutations | Q34738955 | ||
| A rodent model for Wilms tumors: embryonal kidney neoplasms induced by N-nitroso-N'-methylurea | Q35823348 | ||
| Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product | Q36378010 | ||
| A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1 | Q36560249 | ||
| Selective repression of transcriptional activators at a distance by the Drosophila Krüppel protein | Q36702540 | ||
| RNA binding by the Wilms tumor suppressor zinc finger proteins. | Q37426489 | ||
| Alternative splicing and genomic structure of the Wilms tumor gene WT1 | Q37611742 | ||
| Repression of the c-myb gene by WT1 protein in T and B cell lines | Q38290555 | ||
| WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. | Q38295546 | ||
| Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product | Q38298155 | ||
| Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence | Q38338176 | ||
| The regulation of IGF-I receptor gene expression. | Q40381637 | ||
| The genetics of Wilms' tumor--a case of disrupted development | Q40614052 | ||
| Analysis of WT1 target gene expression in stably transfected cell lines | Q41002837 | ||
| The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas | Q41098050 | ||
| The genomic organization and expression of the WT1 gene | Q41120172 | ||
| The transcriptional effect of WT1 is modulated by choice of expression vector | Q41259478 | ||
| The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis | Q41302327 | ||
| Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing | Q41347006 | ||
| New developments in the pathology of Wilms tumor | Q41421689 | ||
| WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. | Q41508164 | ||
| Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome | Q41660674 | ||
| Transcriptional repression mediated by the WT1 Wilms tumor gene product | Q41661461 | ||
| Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development | Q52231802 | ||
| Evidence that WT1 mutations in Denys — Drash syndrome patients may act in a dominant-negative fashion | Q59662118 | ||
| Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript | Q59662123 | ||
| Autoregulation of the human WT1 gene promoter | Q63722729 | ||
| Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1 | Q67493857 | ||
| Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome | Q67510310 | ||
| Langer-Giedion syndrome and deletion of the long arm of chromosome 8 | Q72095894 | ||
| A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome | Q72220079 | ||
| Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour | Q72751031 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 13258-13263 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth control | |
| P478 | volume | 274 |
| Q42830606 | A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1. |
| Q40019105 | A pathologic link between Wilms tumor suppressor gene, WT1, and IFI16. |
| Q44180520 | Analytical validation of a real-time reverse transcription-polymerase chain reaction quantitation of different transcripts of the Wilms' tumor suppressor gene (WT1). |
| Q77378832 | Forced expression of the Wilms tumor 1 (WT1) gene inhibits proliferation of human hematopoietic CD34(+) progenitor cells |
| Q30482686 | In silico regulatory analysis for exploring human disease progression |
| Q34348689 | Life, sex, and WT1 isoforms--three amino acids can make all the difference |
| Q35089301 | Molecular mechanisms of renal development |
| Q40648946 | Oxygen‐regulated expression of the Wilms’ tumor suppressorWt1involves hypoxia‐inducible factor‐1 (HIF‐1) |
| Q28346512 | Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1 |
| Q34820024 | Regulation of gene expression by WT1 in development and tumorigenesis |
| Q34077533 | The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells |
| Q33874404 | The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin |
| Q35779420 | The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. |
| Q28576102 | The Wilms' tumor gene product WT1 mediates the down-regulation of the rat epidermal growth factor receptor by nerve growth factor in PC12 cells |
| Q38352220 | The receptor tyrosine kinase regulator Sprouty1 is a target of the tumor suppressor WT1 and important for kidney development |
| Q36831216 | The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesis |
| Q39371450 | WT1 and Sox11 regulate synergistically the promoter of the Wnt4 gene that encodes a critical signal for nephrogenesis. |
| Q39958704 | WT1 induction of mitogen-activated protein kinase phosphatase 3 represents a novel mechanism of growth suppression |
| Q28191433 | WT1 proteins: functions in growth and differentiation |
| Q36234726 | Wilms' tumour: connecting tumorigenesis and organ development in the kidney |
Search more.